Nutritional Management in Cognitive Impairment and Dementia: A Literature Review

Introduction. The global population aging trend is accompanied by a rise in the number of patients with cognitive impairment and dementia, which requires the search for effective preventive strategies.

Objective. To summarize the current evidence from systematic reviews and meta-analyses on the influence of elderly nutrition (geriatric dietetics) on cognitive health in older adults, and to substantiate the role of dietary strat­egies for risk factor modification in preventing and slowing the progression of cognitive disorders.

Materials and methods. A literature search was performed in Medline, eLibrary, and Cochrane Library databases for the period from October, 2004, to August, 2024, using the keywords “cognitive impairment,” “dementia,” “nutri­tion,” “diet”, and “nutrients.” Over 70 Russianand English-language sources were screened, with preference to prospective cohort studies, randomized controlled trials, systematic reviews, and meta-analyses.

Results. The most robust evidence supports the Mediterranean diet (up to 72% reduction in Alzheimer’s disease risk), mod­erate caffeine intake (70-450 mg/day), moderate calorie restriction, and maintenance of adequate vitamin D levels. In contrast, supplementation with individually taken B vitamins, vitamins C and E, and omega-3 poly­unsaturated fatty acids showed no significant benefit. It is confirmed that timely dietary intervention and adoption of elderly nutrition principles slow cognitive decline.

Discussion. The observed effects are attributed to the antioxidant, anti-inflammatory, and neuroprotective properties of nutrients. Limitations of the evi­dence base include the predominantly observational design of many studies and the short intervention period in several randomized trials.

Conclusion. Integrating elderly nutrition principles into preventive healthcare and patient education may contribute to reducing the burden of dementia. Further long-term interventional studies are warranted.

1. Yakushin M.A., Karpova O.V. MIS “Dementia”. Problems of Geroscience. 2023;(4):280-281. Available from: https://www.geronauka.com/jour/article/view/56 (In Russ.)

2. Parfyonov V.A., Zakharov V.V., Preobrazhenskaya I.S. Cognitive Disorders. Moscow: Remedium Group. 2014. 106 p. (In Russ.)

3. Healthcare in Russia. 2023: Statistical Collection. Moscow: Rosstat. 2023. Available from: https://rosstat.gov.ru/storage/mediabank/Zdravooxran_2023.htm (Accessed January 10, 2026) (In Russ.)

4. Incidence of mental disorders: EMISS data. Rosstat. Available from: https://www.fedstat.ru/indicators/search?searchText=психического (Accessed January 10, 2026) (In Russ.)

5. Kishkun A.A. Biological Age and Aging. Methods of Determination and Ways of Correction: A Guide for Physicians. Moscow: GEOTAR-Media. 2008. p. 62-63. (In Russ.)

6. Statevich N.Yu., Yakushin M.A., Sharoshina K.B. et al. The prevalence of senile asthenia and the analysis of comorbid pathology in people over 60 years of age (analysis of scientific publications). Bulletin of the Medical Dental Institute. 2023;(4):29-30. (In Russ.)

7. Williamson J.D., Pajewski N.M., Auchus A.P. et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321(6):553-561. https://doi.org/10.1001/jama.2018.21442

8. Blinkova L.N. Organizational aspects of nutrition in the elderly. Problems of Nutrition. 2014;83(S3):13. Available from: https://elibrary.ru/item.asp?id=27426967 (In Russ.)

9. Alsharidah M., Murtaza A., Alsharidah G.M. et al. Fasting in Ramadan Affects Cognitive and Physiological Function in Normal Subjects (Pilot Study). Neuroscience and Medicine. 2016;7:60-65. https://doi.org/10.4236/nm.2016.72007

10. Valabhji J., Gorton T., Barron E. et al. Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation. The Lancet Diabetes & Endocrinology. 2024;12(9):653-663. https://doi.org/10.1016/S2213-8587(24)00194-3

11. Singh B., Parsaik A.K., Mielke M.M. et al. Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease. 2014;39(2):271-282. https://doi.org/10.3233/JAD-130830

12. Grinyuk V.V. The evolution of non-drug therapy for cognitive impairment. Behavioral Neurology. 2024;(1):44-51. Available from: https://cyberleninka.ru/article/n/evolyutsiya-nelekarstvennoy-terapii-kognitivnyh-narusheniy (In Russ.)

13. García-Casares N., Gallego Fuentes P., Barbancho M.Á. et al. Alzheimer’s Disease, Mild Cognitive Impairment and Mediterranean Diet. A Systematic Review and Dose-Response Meta-Analysis. Journal of Clinical Medicine. 2021;10(20):4642. https://doi.org/10.3390/jcm10204642

14. Ballarini T., van Lent D.M., Brunner J. et al. Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age. Neurology. 2021;96(24):e2920-e2932. https://doi.org/10.1212/WNL.0000000000012067

15. Gu Y., Luchsinger J.A., Stern Y., Scarmeas N. Mediterranean Diet, Inflammatory and Metabolic Biomarkers, and Risk of Alzheimer’s Disease. Journal of Alzheimer’s Disease. 2010;22(2):483-492. https://doi.org/10.3233/JAD-2010-100897

16. Barnes L.L., Dhana K., Liu X. et al. Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons. New England Journal of Medicine. 2023;389:602-611. https://doi.org/10.1056/NEJMoa2302368

17. Tutelyan V.A., Onishchenko G.G., Skalny A.V. et al. Methodological Recommendations MR 2.3.1.1915-04 “Recommended Levels of Consumption of Food and Biological Substances”. Moscow. 2004. 36 p. Available from: https://base.garant.ru/4180742/ (In Russ.)

18. Larrieu S., Letenneur L., Helmer C. et al. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. Journal of Nutrition, Health and Aging. 2004;8(3):150-154. Available from: https://www.researchgate.net/publication/8576933_Nutritional_factors_and_risk_of_incident_dementia_in_the_PAQUID_longitudinal_cohort

19. Liu C.B., Wang R., Yi Y.F. et al. Lycopene mitigates -amyloid induced inflammatory response and inhibits NF- B signaling at the choroid plexus in early stages of Alzheimer’s disease rats. Journal of Nutritional Biochemistry. 2018;53:66-71. https://doi.org/10.1016/j.jnutbio.2017.10.014

20. Wang J., Li L., Wang Z. et al. Supplementation of lycopene attenuates lipopolysaccharide-induced amyloidogenesis and cognitive impairments via mediating neuroinflammation and oxidative stress. Journal of Nutritional Biochemistry. 2018;56:16-25. https://doi.org/10.1016/j.jnutbio.2018.01.009

21. Johnson E.J. Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutrition Reviews. 2014;72(9):605-612. https://doi.org/10.1111/nure.12133

22. Liu Q.-P., Wu Y.F., Cheng H.Y. et al. Habitual coffee consumption and risk of cognitive decline/dementia: A systematic review and meta-analysis of prospective cohort studies. Nutrition. 2016;32(6):628-636. https://doi.org/10.1016/j.nut.2015.11.015

23. Camandola S., Plick N., Mattson M.P. Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease. Neurochemical Research. 2019;44(1):214-227. https://doi.org/10.1007/s11064-018-2492-0

24. Colombo R., Papetti A. An outlook on the role of decaffeinated coffee in neurodegenerative diseases. Critical Reviews in Food Science and Nutrition. 2020;60(5):760-779. https://doi.org/10.1080/10408398.2018.1550384

25. Nabbi-Schroeter D., Elmenhorst D., Oskamp A. et al. Effects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX. Molecular Imaging and Biology. 2018;20(2):284-291. https://doi.org/10.1007/s11307-017-1116-4

26. Cho B.H., Choi S.M., Kim J.T., Kim B.C. Association of coffee consumption and non-motor symptoms in drug-naïve, early-stage Parkinson’s disease. Parkinsonism and Related Disorders. 2018;50:42-47. https://doi.org/10.1016/j.parkreldis.2018.02.016

27. Scheperjans F., Pekkonen E., Kaakkola S. et al. Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota? Journal of Parkinson’s Disease. 2015;5(2):255-262. https://doi.org/10.3233/JPD150557

28. Annweiler C. Vitamin D in dementia prevention. Annals of the New York Academy of Sciences. 2016;1367(1):57-63. https://doi.org/10.1111/nyas.13058

29. Cui X., Pelekanos M., Burne T.H. et al. Maternal vitamin D deficiency alters the expression of genes involved in dopamine specification in the developing rat mesencephalon. Neuroscience Letters. 2010;486(3):220-223. https://doi.org/10.1016/j.neulet.2010.09.057

30. Cui X., Pelekanos M., Liu P.Y. et al. The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience. 2013;236:77-87. https://doi.org/10.1016/j.neuroscience.2013.01.035

31. Kesby J.P., Cui X., O’Loan J. et al. Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats. Psychopharmacology. 2010;208(1):159- 168. https://doi.org/10.1007/s00213-009-1717-y

32. Jayedi A., Rashidy-Pour A., Shab-Bidar S. Vitamin D status and risk of dementia and Alzheimer’s disease: A meta-analysis of dose-response. Nutritional Neuroscience. 2019;22(11):750-759. https://doi.org/10.1080/1028415X.2018.1436639

33. Llewellyn D.J., Lang I.A., Langa K.M. et al. Vitamin D and risk of cognitive decline in elderly persons. Archives of Internal Medicine. 2010;170(13):1135-1141. https://doi.org/10.1001/archinternmed.2010.173

34. Moore C., Murphy M.M., Keast D.R. et al. Vitamin D intake in the United States. Journal of the American Dietetic Association. 2004;104(6):980-983. https://doi.org/10.1016/j.jada.2004.03.028

35. Andrews V., Zammit G., O’Leary F. Dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews. Nutrition Reviews. 2023;81(11):1462-1489. https://doi.org/10.1093/nutrit/nuad013

36. Del Parigi A., Panza F., Capurso C. et al. Nutritional factors, cognitive decline, and dementia. Brain Research Bulletin. 2006;69(1):1-19. https://doi.org/10.1016/j.brainresbull.2005.09.020

37. Cattaneo A., Cattane N., Galluzzi S. et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiology of Aging. 2017;49:60-68. https://doi.org/10.1016/j.neurobiolaging.2016.08.019

38. Gu S.L., Gong Y., Zhang J. et al. Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota. Infection and Drug Resistance. 2020;13:4547-4558. https://doi.org/10.2147/IDR.S281274

39. Tian J., Lu Y., Zhang H. et al. Gamma-Aminobutyric Acid Inhibits T Cell Autoimmunity and the Development of Inflammatory Responses in a Mouse Type 1 Diabetes Model. Journal of Immunology. 2004;173(8):5298-5304. https://doi.org/10.4049/jimmunol.173.8.5298

40. Dalal R., McGee R.G., Riordan S.M. et al. Probiotics for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews. 2017;2:CD008716. https://doi.org/10.1002/14651858.CD008716.pub3

41. Kornerup L.S., Gluud L.L., Vilstrup H. et al. Update on the Therapeutic Management of Hepatic Encephalopathy. Current Gastroenterology Reports. 2018;20(5):21. https://doi.org/10.1007/s11894-018-0627-8

42. Blinkova L.N., Yakushin M.A., Karpova O.V. Nutrition management for cognitive disorders and dementia (overview). Problems of Social Hygiene, Public Health and History of Medicine. 2025;33(3):494-501. http://dx.doi.org/10.32687/0869-866X-2025-33-3-494-501 (In Russ.)